TREATMENT OF ARDS ASSOCIATED WITH COVID-19

Type: Pharmaceuticals
Sector: Infectious Diseases-Microbiology-Virology

This project,is acollaboration of Prof. Yoram Weiss from Hadassah, Prof. Yechezkel Barenholzfrom HUJIand Prof. Goloubinoff from the University of Lausanne (Switzerland),aiming to treat Acute Respiratory Distress Syndrome (ARDS) by using a specifically adaptedformulation.

The project takesadvantage of aspecific active ingredient whose feasibility has been tested in vitro and in vivo.

Existing animal models and materials are availablefor thedevelopment.